980 THE JOURNAL OF BONE AND JOINT SURGERY
ONCOLOGY
The final diagnosis in patients with a
suspected primary malignancy of bone
A. M. Malhas,
R. J. Grimer,
A. Abudu,
S. R. Carter,
R. M. Tillman,
L. Jeys
From The Royal
Orthopaedic
Hospital,
Birmingham, United
Kingdom
A. M. Malhas, MRCS, MSc,
Specialist Registrar
R. J. Grimer, FRCS,
Consultant Orthopaedic
Surgeon
A. Abudu, FRCS, Consultant
Orthopaedic Surgeon
S. R. Carter, FRCS,
Consultant Orthopaedic
Surgeon
R. M. Tillman, FRCS,
Consultant Orthopaedic
Surgeon
L. Jeys, FRCS, Consultant
Orthopaedic Surgeon
The Royal Orthopaedic Hospital
Oncology Service
The Royal Orthopaedic
Hospital, Bristol Road South,
Birmingham B31 2AP, UK.
Correspondence should be sent
to Mr R. J. Grimer; e-mail:
robert.grimer@nhs.net
©2011 British Editorial Society
of Bone and Joint Surgery
doi:10.1302/0301-620X.93B7.
25727 $2.00
J Bone Joint Surg [Br]
2011;93-B:980-3.
Received 17 August 2010;
Accepted after revision 29
March 2011
We investigated the eventual diagnosis in patients referred to a tertiary centre with a
possible diagnosis of a primary bone malignancy.
We reviewed our database from between 1986 and 2010, during which time 5922 patients
referred with a suspicious bone lesion had a confirmed diagnosis. This included bone
sarcoma in 2205 patients (37%), benign bone tumour in 1309 (22%), orthopaedic conditions
in 992 (17%), metastatic disease in 533 (9%), infection in 289 (5%) and haematological
disease in 303 (5%). There was a similar frequency of all diagnoses at different ages except
for metastatic disease. Only 0.6% of patients (17 of 2913) under the age of 35 years had
metastatic disease compared with 17.1% (516 of 3009) of those over 35 years (p < 0.0001). Of
the 17 patients under 35 years with metastatic disease, only four presented with an isolated
lesion, had no past history of cancer and were systematically well.
Patients under the age of 35 years should have suitable focal imaging (plain radiography,
CT or MRI) and simple systemic studies (blood tests and chest radiography). Reduction of
the time to biopsy can be achieved by avoiding an unnecessary investigation for a primary
tumour to rule out metastatic disease.
Bone and soft-tissue sarcomas represent less
than 1% of all malignant tumours.
1,2
Delays in
diagnosis and a wide range of differential diag-
noses are common.
3
These include infections,
benign tumours, normal variants, degenerative
or metabolic processes and other malignant
tumours. Reaching the correct diagnosis in the
quickest time possible is essential for the patient
and important for resource allocation.
4-7
Current guidelines from the National Insti-
tute for Clinical Excellence (NICE)
2
recom-
mend that any patient presenting with bone
pain or swelling (in particular, pain not aggra-
vated by activity) should be referred for radio-
graphy.
8
Any suspicious lesion with bone lysis,
formation of new bone, periosteal elevation or
soft-tissue swelling, should be investigated fur-
ther. If a bone sarcoma is considered to be a
possibility, the patient should be referred
directly to a specialist bone-tumour unit,
whereas, if metastasis is suspected, investiga-
tion locally is appropriate.
9
For more than 30 years, our centre has
accepted referrals from patients who might
have a primary malignant bone tumour. Our
aim in this study was to analyse the correct
diagnosis in all such patients and to define
patterns which might lead to clearer guidelines
for referral.
Patients and Methods
We searched our database for all patients
referred with a possible primary malignant
bone tumour between 1986 and 2010. Patients
with a known diagnosis of a bone metastasis or
benign tumour were excluded. Most were
thought to have had a possible primary malig-
nant bone tumour before referral, but in most
cases no definite diagnosis had been made and
the patients were referred for investigation,
diagnosis and advice on treatment. In almost
all a ‘suspicious’ plain radiograph had been
obtained before referral, but the extent of fur-
ther investigations varied widely, with some
having had none and others having had CT of
the chest and abdomen, bone scanning and
MRI of the primary site.
All the patients were investigated according
to a protocol designed to reach a diagnosis as
quickly as possible. In some cases targeted
investigations could reach a diagnosis without a
biopsy, for example, CT revealing a typical
osteoid osteoma. In most, however, the investi-
gations included a full history and examination
followed by local and systemic imaging. Local
imaging was usually CT before 1993 and MRI
afterwards. Systemic imaging included bone
scanning and chest radiography and in some
cases of possible metastatic disease, CT of the